Month: November 2019
Investor Presentation 10th Annual Jefferies Global Healthcare Conference 21 November 2019
ObsEva to participate in The Credit Suisse Healthcare Conference, November 11-13, 2019
Fireside Chat Scottsdale, AZ Wednesday, November 13 at 8:00 a.m. Mountain Time (MT).
Third Quarter 2019 Financial Results 7 November 2019
ObsEva Announces Third Quarter 2019 Financial Results
– Reports Update on Three Women’s Health Product Candidates – – Focusing on Phase 3 Programs for Linzagolix and the…
Q3 Report 2019
Obseva Announces That Nolasiban Implant 4 Study Did Not Meet Primary Endpoint
Company to Discontinue Current Nolasiban IVF Program Geneva, Switzerland and Boston, MA – November 7, 2019 – ObsEva SA (NASDAQ:…
ObsEva SA to Hold Conference Call to Discuss IMPLANT 4 Trial Results and Third Quarter 2019 Financial and Business Update on November 7, 2019
Geneva, Switzerland and Boston, MA –November 6, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing…
ObsEva SA to Participate in Upcoming Investor Conferences
Geneva, Switzerland and Boston, MA – November 6, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company…
ObsEva SA to Hold Third Quarter 2019 Financial Results and Business Update Call on November 11, 2019
Geneva, Switzerland and Boston, MA –November 4, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical…